financetom
Business
financetom
/
Business
/
Salesforce Left Revenue Outlook Unchanged Again, Despite AI Momentum, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce Left Revenue Outlook Unchanged Again, Despite AI Momentum, UBS Says
Sep 4, 2025 1:55 PM

04:17 PM EDT, 09/04/2025 (MT Newswires) -- Salesforce ( CRM ) didn't raise its fiscal 2026 sales outlook for the second quarter in a row, despite strong growth in the data cloud and artificial intelligence segments, UBS Securities said Thursday.

Late Wednesday, the customer relationship management platform maintained its full-year constant-currency revenue growth outlook at 8%. The company posted stronger-than-expected second-quarter results.

The unchanged guidance came even as management was upbeat on the second-half pipeline and bookings momentum, UBS analyst Karl Keirstead said in a note to clients.

"This in our view speaks to a quite mature CRM software market and a reality that 'front-office AI' investments are simply very early-stage," Keirstead wrote. "We're content staying patient on the stock until we can more clearly see a path back to (10%-plus) growth."

Salesforce ( CRM ) shares declined nearly 4.9% at market close on Thursday. The stock has lost nearly 27% in value so far this year.

For the ongoing three-month period, the company projects revenue to rise 8% to 9% year over year to between $10.24 billion and $10.29 billion, which would mark a deceleration from 10% growth reported for the second quarter. The Street was projecting $10.29 billion in third-quarter revenue on Wednesday.

UBS expects subdued investor sentiment due to the projected sequential deceleration, as well as "the lack of any upside" to the company's full-year outlook despite the robust growth in AI and data, according to the note.

"Salesforce ( CRM ) did sound confident in the (fourth-quarter) pipeline and bookings, messaging that a material (fourth-quarter) deceleration in (current remaining performance obligation) was unlikely," Keirstead said. "But we'd argue that (software-as-a-service)/apps investor sentiment is such that investors will need more tangible proof points that Salesforce's ( CRM ) growth is setting up to accelerate to (10%-plus in 2027) to come back to the stock."

The brokerage maintained its neutral rating and a $260 price target on the Salesforce ( CRM ) stock.

The company now expects its planned acquisition of cloud data management firm Informatica ( INFA ) to close in its 2026 fiscal fourth quarter or early in 2027, Salesforce ( CRM ) Chief Operating and Financial Officer Robin Washington said on an earnings conference call late Wednesday, according to a FactSet transcript. "At this time, given the variability and potential closing timing, we have not included any contribution from Informatica ( INFA ) in our guidance."

Salesforce ( CRM ) agreed to acquire Informatica ( INFA ) in May in a deal worth about $8 billion. The companies said at the time that they expected the deal to be completed early in Salesforce's ( CRM ) fiscal 2027.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US targets Novo Nordisk's Ozempic and Wegovy for Medicare price talks
US targets Novo Nordisk's Ozempic and Wegovy for Medicare price talks
Jan 17, 2025
WASHINGTON, Jan 17 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday. Other drugs on the list include Pfizer's ( PFE ) cancer drugs Ibrance and Xtandi, GSK's asthma and chronic obstructive pulmonary disease (COPD) treatment Trelegy Ellipta, Teva's...
Activist investor Starboard Value takes 7.7% stake in chipmaker Qorvo
Activist investor Starboard Value takes 7.7% stake in chipmaker Qorvo
Jan 17, 2025
Jan 17 (Reuters) - Starboard Value has built a 7.7% stake in Qorvo ( QRVO ), the chipmaker revealed in a filing on Friday, as the activist investor looks to boost the company's weak share price. ...
Fastenal misses estimates amid sluggish demand for industrial safety products
Fastenal misses estimates amid sluggish demand for industrial safety products
Jan 17, 2025
Jan 17 (Reuters) - Fastenal ( FAST ) posted fourth-quarter profit below analysts' estimates on Friday, as a sustained slowdown in construction sector dented demand for its fasteners and other safety products. Shares of the Winona, Minnesota-based company fell 5.7% in premarket trading. U.S. construction activity has slowed due to increased financing costs for big projects amid higher interest rates,...
Why Is Versus Systems Stock Rocketing Today?
Why Is Versus Systems Stock Rocketing Today?
Jan 17, 2025
Versus Systems Inc. ( VS ) shares are trading higher premarket on Friday. On Thursday, the company expanded into Brazil to strengthen its international presence. Also, the company plans to enhance its gamification platform’s impact on audience engagement across industries. Versus Systems ( VS ) has appointed Flavio Maria as the Country Manager for Brazil, one of the largest global...
Copyright 2023-2026 - www.financetom.com All Rights Reserved